Express News | Bright Minds Biosciences Brief: Announcing "Positive" QEEG (Quantitative Electroencephalogram) Data From Its First-in-Human Phase 1 Study of Lead Compound, BMB-101

Moomoo 24/7Aug 8, 2023 06:58 ET

Express News | Bright Minds Biosciences Brief: Announced "Positive" Topline Data for Its First-in-Human Phase 1 Study of Lead Compound, BMB-101

Moomoo 24/7Jul 20, 2023 06:54 ET

CSE Bulletin: Consolidation - Bright Minds Biosciences Inc. (DRUG)

Toronto, Ontario--(Newsfile Corp. - Le 12 juillet/July 2023) - Bright Minds Biosciences Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-cons

newsfileJul 12, 2023 10:33 ET

Bright Minds Announces Effective Date of Share Consolidation

Stockhouse Jul 11, 2023 06:50 ET

Bright Minds Biosciences Brief: Says Received a "Favorable" Written Opinion From International Searching Authority for BMB-202

06:53 AM EDT, 04/19/2023 (MT Newswires) -- Bright Minds Biosciences Brief: Says Received a "Favorable" Written Opinion from International Searching Authority for BMB-202

MT NewswiresApr 19, 2023 07:07 ET

Short Interest in Bright Minds Biosciences Inc. (NASDAQ:DRUG) Decreases By 11.6%

Bright Minds Biosciences Inc. (NASDAQ:DRUG – Get Rating) was the target of a significant decline in short interest in the month of November. As of November 30th, there was short interest totalling 82

Defense WorldDec 20, 2022 04:01 ET